Although the activation and expansion of T cells through the lack of negative regulation by PD-1 and CTLA-4 are considered the immune pathogenesis of irAEs, the molecular mechanisms underlying the development of liver irAE remain unclear (19). The gene discussed is CTLA4; the disease is medical procedure.